Translational Paradigms in Cerebrovascular Gene Transfer

Journal of Cerebral Blood Flow and Metabolism

Volumn 23, Issue 11, 2003, Pages 1251-1262

  Khurana, Vini G ^a   Meyer, Fredric B ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Adenovirus; Cerebral vasospasm; Gene therapy; Nitric oxide; Subarachnoid hemorrhage

Indexed keywords

GENE PRODUCT;

BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN VASOSPASM; DNA MODIFICATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; SUBARACHNOID HEMORRHAGE;

EID: 0242658592     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WCB.0000093324.07718.D4     Document Type: Review

References (82)

1. Akiyama M, Eguchi D, Weiler D, O'Brien T, Kovesdi I, Scotland R, Sessa WC, Katusic ZS (2002) Expression and function of recombinant S1179D endothelial nitric oxide synthase in canine cerebral arteries. Stroke 33:1071-1076
2. Anderson RE, Meyer FB (2000) Is intracellular brain pH a dependent factor in NOS inhibition during focal cerebral ischemia? Brain Res 856:220-226
3. Balicki D, Beutler E (2002) Gene therapy of human disease. Medicine 81:69-86
4. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323
5. Blau HM, Springer ML (1995) Gene therapy-a novel form of drug delivery. N Engl J Med 333:1204-1207
6. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA (1994) Nitric oxide directly activates calcium dependent potassium channels in vascular smooth muscle. Nature 368:850-853
7. Brenner M (2000) Reports of adenovector "death" are greatly exaggerated. Mol Ther 1:205
8. Caplice NM (2001) Biologic alternatives to stents and grafts. Curr Cardiol Rep 3:17-21
9. Channon KM, Blazing MA, Shetty GA, Potts KE, George SE (1996) Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc Res 32:962-972
10. Chen AFY, Jiang SW, Crotty TB, Tsutsui M, Smith LA, O'Brien T, Katusic ZS (1997a) Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Natl Acad Sci U S A 94:12568-12573
11. Chen AFY, O'Brien T, Katusic ZS (1998) Transfer and expression of recombinant nitric oxide synthase genes in the cardiovascular system. Trends Pharmacol Sci 19:276-286
12. Chen AFY, O'Brien T, Tsutsui M, Kinoshita H, Pompili VJ, Crotty TB, Spector DJ, Katusic ZS (1997b) Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. Circ Res 80:327-335
13. Christenson SD, Lake KD, Ooboshi H, Faraci FM, Davidson BL, Heistad DD, Finklestein SP (1998) Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue in mice. Stroke 29:1411-1416
14. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ (1993) A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 3:219-223
15. De Belder AJ, Radomski MW (1994) Nitric oxide in the clinical arena. J Hypertens 12:617-624
16. Dietrich HH, Dacy RG Jr (2000) Molecular keys to the problems of cerebral vasospasm. Neurosurgery 46:517-530
17. Dyer MR, Herrling PL (2000) Progress and potential for gene-based medicines. Mol Ther 1:213-224
18. Eguchi D, Weiler D, Alam J, Nath K, Katusic ZS (2001) Protective effect of heme oxygenase-1 gene transfer against oxyhemoglobin endothelial dysfunction. J Cereb Blood Flow Metab 21:1215-1222
19. Fleming I, Busse R (1999) Signal transduction of eNOS activation. Cardiovasc Res 43:532-541
20. Freedman S B, Isner JM (2001) Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 33:379-93
21. Friedmann T, Roblin R (1972) Gene therapy for human genetic disease? Proposals for genetic manipulation in humans raise difficult scientific and ethical problems. Science 175:949-955
22. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC (1999) Regulation of endothelium-derived nitric oxide by the protein kinase Akt. Nature 399:597-601
23. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376
24. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC (1998) Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392:821-824
25. Gunnett CA, Heistad DD (2001) The future of gene therapy for stroke. Curr Hypertens Rep 3:36-40
26. Gunnett CA, Heistad DD (2002) Virally mediated gene transfer to the vasculature. Microcirculation 9:23-33
27. Gunnett CA, Lund DD, Howard MA III, Chu Y, Faraci FM, Heistad DD (2002) Gene transfer of inducible nitric oxide synthase impairs relaxation in human and rabbit cerebral arteries. Stroke 33:2292-2296
28. Heistad DD, Faraci FM (1996) Gene therapy for cerebral vascular disease. Stroke 27:1688-1693
29. Hobbs AJ, Higgs A, Moncada S (1999) Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39:191-220
30. Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7:33-40
31. Khurana VG. Besser M (1997) Pathophysiological basis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Clin Neurosci 4:122-131
32. Khurana VG, Feterik K, Eguchi D, Springett MJ, Shah V, Katusic ZS (2000a) Functional interdependence and colocalization of endothelial nitric oxide synthase (eNOS) and heat-shock protein 90 (HSP90) in cerebral arteries. J Cereb Blood Flow Metab 20:1563-1570
33. Khurana VG, Katusic ZS (2001) Gene transfer for cerebrovascular disease. Curr Cardiol Rep 3:10-16
34. Khurana VG, Smith LA, Baker TA, Eguchi D, O'Brien T, Katusic ZS (2002) Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke 33:782-789
35. Khurana VG, Smith LA, Weiler DA, Springett MJ, Parisi JE, Meyer FB, Marsh WR, O'Brien T, Katusic ZS (2000b) Adenovirus-mediated gene transfer to human cerebral arteries. J Cereb Blood Flow Metab 20:1360-1371
36. Khurana VG, Weiler DA, Witt TA, Smith LA, Kleppe LS, Parisi JE, Simari RD, O'Brien T, Russell SJ, Katusic ZS (2003) A direct mechanical method for accurate and efficient adenoviral vector delivery to tissues. Gene Ther 10:443-452
37. Kibbe M, Billiar T, Tzeng E (1999) Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 43:650-657
38. Kim S, Lin H, Barr E, Chu L, Leiden JM, Parmacek MS (1997) Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest 100:1006-1014
39. Kullo IJ, Mozes G, Schwartz RS, Gloviczki P, Tsutsui M, Katusic ZS, O'Brien T (1997) Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. Hypertension 30:314-320
40. Laitinen M, Hartikainen J, Hiltunen MO, Erananen J, Kiviniemi M, Narvanen O, Makinen K, Manninen H, Syvanne M, Martin JF, Laakso M, Yla-Herttuala S (2000) Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther 11:263-270
41. Lin H, Lin TN, Cheung WM, Nian GM, Tseng PH, Chen SF, Chen JJ, Shyue SK, Liou JY, Wu CW, Wu KK (2002) Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation 105:1962-1969
42. Luders JC, Weihl CC, Lin G, Ghadge G, Stoodley M, Roos RP, Macdonald RL (2000) Adenoviral gene transfer of nitric oxide synthase increases cerebral blood flow in rats. Neurosurgery 47:1206-1215
43. Lund DD, Faraci FM, Ooboshi H, Davidson BL, Heistad DD (1998) Adenovirus-mediated gene transfer is augmented in basilar and carotid arteries of heritable hyperlipidemic rabbits. Stroke 29:120-125
44. Meyer FB, Sundt TM Jr, Yanagihara T, Anderson RE (1987) Focal cerebral ischemia: pathophysiologic mechanisms and rationale for future avenues of treatment. Mayo Clin Proc 62:35-55
45. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142
46. Muhonen MG, Ooboshi H, Welsh MJ, Davidson BL, Heistad DD (1997) Gene transfer to cerebral blood vessels after subarachnoid hemorrhage. Stroke 28:822-829
47. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA (1995) Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 96:2955-2965
48. Ono S, Date I, Onoda K, Shiota T, Ohmoto T, Ninomiya Y, Asari S, Morishita R (1998) Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy. Hum Gene Ther 9:1003-1011
49. Ono S, Komuro T, Macdonald RL (2002) Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg 96:1094-1102
50. Onoue H, Tsutsui M, Smith L, O'Brien T, Katusic ZS (1999) Adventitial expression of recombinant endothelial nitric oxide synthase gene reverses vasoconstrictor effect of endothelin-1. J Cereb Blood Flow Metab 19:1029-1037
51. Onoue H, Tsutsui M, Smith L, Stelter A, O'Brien T, Katusic ZS (1998) Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 29:1959-1966
52. Ooboshi H, Welsh MJ, Rios CD, Davidson BL, Heistad DD (1995) Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res 77:7-13
53. Papadopoulos MC, Giffard RG, Bell BA (2000) Principles of gene therapy: potential applications in the treatment of cerebral ischemia. Br J Neurosurg 14:407-414
54. Regli L, Held MC, Anderson RE, Meyer FB (1996) Nitric oxide synthase inhibition by L-NAME prevents brain acidosis during focal cerebral ischemia in rabbits. J Cereb Blood Flow Metab 16:988-995
55. Richter M, Iwata A, Nyhuis J, Nitta Y, Miller AD, Halbert CL, Allen MD (2000) Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol Genomics 2:117-127
56. Satoh M, Perkins E, Kimura H, Tang J, Chun Y, Heistad DD, Zhang JH (2002) Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs. J Neurosurg 97:136-142
57. Stoodley M, Weihl CC, Zhang ZD, Lin G, Johns LM, Kowalczuk A, Ghadge G, Roos RP, Macdonald RL (2000) Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 45:1193-1203
58. Szabo C, Salzman AL, Ischiropoulos H (1995) Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett 363:235-238
59. Thomas CE, Schiedner G, Kochanek S, Castro MG, Lowenstein PR (2000) Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic disease. Proc Natl Acad Sci U S A 97:7482-7487
60. Thomas JE, Rosenwasser RH, Armondo RA, Harrop J, Mitchell W, Galaria I (1999) Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 30:1409-1416
61. Toyoda K, Andresen JJ, Zabner J, Faraci FM, Heistad DD (2000a) Calcium phosphate precipitates augment adenovirus-mediated gene transfer to blood vessels in vitro and in vivo. Gene Ther 7:1284-1291
62. Toyoda K, Faraci FM, Russo AF, Davidson BL, Heistad DD (2000b) Gene transfer of calcitonin gene-related peptide to cerebral arteries. Am J Physiol 278:H586-H594
63. Toyoda K, Faraci FM, Watanabe Y, Ueda T, Andresen JJ, Chu Y, Otake S, Heistad DD (2000c) Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ Res 87:818-824
64. Toyoda K, Nakane H, Heistad DD (2001) Cationic polymer and lipids augment adenovirus-mediated gene transfer to cerebral arteries in vivo. J Cereb Blood Flow Metab 21:1125-1131
65. Tsutsui M, Chen AFY, O'Brien T, Crotty TB, Katusic ZS (1998) Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium. Anterioscler Thromb Vasc Biol 18:1231-1241
66. Tsutsui M, Onoue H, Iida Y, Smith L, O'Brien T, Katusic ZS (1999) Adventitia-dependent relaxations of canine basilar arteries transduced with recombinant eNOS gene. Am J Physiol 276:H1846-H1852
67. 2 bradykinin receptors on adventitial fibroblasts of cerebral arteries are coupled to recombinant eNOS. Am J Physiol 278:H367-H372
68. Tsutsui M, Onoue H, Iida Y, Smith L, O'Brien T, Katusic ZS (2000b) Effects of recombinant eNOS gene expression on reactivity of small cerebral arteries. Am J Physiol 278:H420-H427
69. Ueki K, Meyer FB, Mellinger JF (1994) Moyamoya disease: the disorder and surgical treatment. Mayo Clin Proc 69:749-757
70. Vanhoutte PM (1999) How to assess endothelial function in human blood vessels. J Hypertens 17:1047-1058
71. Vassalli G, Agah R, Qiao R, Aguilar C, Dichek DA (1999) A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression. Circ Res 85:e25-e32
72. Verma IM (2003) A voluntary moratorium? Mol Ther 7:141
73. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ (1995) Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 92:1137-1141
74. Vorburger SA, Hunt KK (2002) Adenoviral gene therapy. Oncologist 7:46-59
75. Watanabe Y, Chu Y, Andresen JJ, Nakane H, Faraci FM, Heistad DD (2003) Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 34:434-440
76. Weihl C, Macdonald RL, Stoodley M, Luders J, Lin G (1999) Gene therapy for cerebrovascular disease. Neurosurgery 44:239-252
77. Weir B (1995) The pathophysiology of cerebral vasospasm. Br J Neurosurg 9:375-390
78. Wen S, Schneider DB, Driscoll RM, Vassalli G, Sassani AB, Dichek DA (2000) Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wall. Anterioscler Thromb Vasc Biol 20:1452-1458
79. vβ5 promote adenovirus internalization but not virus attachment. Cell 73:309-319
80. Wood MJA, Charlton HM, Wood KJ, Kajiwara K, Byrnes AP (1996) Immune responses to adenovirus vectors in the nervous system. Trends Neurosci 19:497-501
81. Wu JC, Inubushi M, Sundaresan G, Schelbert HR, Gambhir SS (2002) Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106:180-183
82. Yenari MA, Dumas TC, Sapolsky RM, Steinberg GK (2001) Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors. Ann N Y Acad Sci 939:340-357